Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Bunge Limited, 2 years.
Bunge Limited
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Bunge Limited May 20, 202693.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | Bunge Limited | Grant or award | +20 | $119.25 | $2,385 |
| Jun 1, 2026 | Bunge Limited | Grant or award | +18 | $126.92 | $2,285 |
| May 20, 2026 | Bunge Limited | Grant or award | +3,308 | — | — |
| May 15, 2026 | Bunge Limited | Shares withheld for tax | −1,213 | $122.68 | $148,811 |
| Mar 3, 2026 | Bunge Limited | Grant or award | +28 | $116.83 | $3,271 |
| Dec 1, 2025 | Bunge Limited | Grant or award | +34 | $96.47 | $3,280 |
| Sep 2, 2025 | Bunge Limited | Grant or award | +39 | $82.44 | $3,215 |
| Jun 2, 2025 | Bunge Limited | Grant or award | +41 | $77.87 | $3,193 |
| May 15, 2025 | Bunge Limited | Shares withheld for tax | −753 | $79.65 | $59,976 |
| May 15, 2025 | Bunge Limited | Grant or award | +4,707 | — | — |
| Mar 4, 2025 | Bunge Limited | Grant or award | +27 | $71.86 | $1,940 |
| Dec 2, 2024 | Bunge Limited | Grant or award | +22 | $88.62 | $1,950 |
| Sep 2, 2024 | Bunge Limited | Grant or award | +19 | $100.95 | $1,918 |
| Jun 3, 2024 | Bunge Limited | Grant or award | +18 | $107.37 | $1,933 |
| May 15, 2024 | Bunge Limited | Grant or award | +2,920 | — | — |
Questions about Mark N. Zenuk
What boards is Mark N. Zenuk on?
Mark N. Zenuk sits on the board of Bunge Limited.
How long has Mark N. Zenuk served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.